Statin Therapy In Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

1,922

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Atrial FibrillationMyocardium; Injury
Interventions
DRUG

Rosuvastatin

Rosuvastatin (20 mg od) started not earlier than 8 days before surgery and continued until the 5th post-operative day included;

DRUG

Placebo

Placebo started not earlier than 8 days before surgery and continued until the 5th post-operative day included.

Trial Locations (1)

100037

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

Chinese Academy of Medical Sciences

OTHER

collaborator

Peking Union Medical College

OTHER

lead

University of Oxford

OTHER

NCT01573143 - Statin Therapy In Cardiac Surgery | Biotech Hunter | Biotech Hunter